Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous Tumors
Alpha Tau Medical LTD.
80 participants
Apr 1, 2022
INTERVENTIONAL
Conditions
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Seed(s) loaded with Radium-224 for local intratumoral irradiation with the destructive power of alpha particles
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04068155